| Literature DB >> 26584463 |
Detlev H Kruger, Evgeniy A Tkachenko, Vyacheslav G Morozov, Yulia V Yunicheva, Olga M Pilikova, Gennadiy Malkin, Aydar A Ishmukhametov, Patrick Heinemann, Peter T Witkowski, Boris Klempa, Tamara K Dzagurova.
Abstract
Sochi virus was recently identified as a new hantavirus genotype carried by the Black Sea field mouse, Apodemus ponticus. We evaluated 62 patients in Russia with Sochi virus infection. Most clinical cases were severe, and the case-fatality rate was as high as 14.5%.Entities:
Keywords: Apodemus ponticus; Hantavirus; Russia; Sochi virus; hemorrhagic fever with renal syndrome; viruses
Mesh:
Substances:
Year: 2015 PMID: 26584463 PMCID: PMC4672424 DOI: 10.3201/eid2112.150891
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Figure 1Phylogenetic analysis segment sequences of Sochi virus, Russia: A) 347-bp large (L) segment sequence; B) 1,197-bp small (S) segment sequence. Virus sequences derived from patients (shown in bold type) and Apodemus ponticus mice cluster within the Sochi genotype of DOBV. Evolutionary analysis was conducted in MEGA6 (). The evolutionary history was inferred by using the maximum-likelihood method based on the Tamura 3-parameter model with a discrete gamma distribution and 5 rate categories (analysis in panel A) and on the general time reversible model with gamma rates and heterogeneous patterns (analysis in panel B), respectively, which were estimated to be the best-fit substitution model according to the Bayesian information criterion. Scale bars indicate an evolutionary distance of 0.1 substitutions per position in the sequence. Bootstrap values >70%, calculated from 500 replicates, are shown at the tree branches. GenBank accession numbers of all sequences used in the analysis are listed in Technical Appendix Table 1). Dark gray shading iindicates cluster of DOBV-Sochi strains; light gray shading indicates different clusters of strains from other DOBV genotypes. ANDV, Andes virus; DOBV, Dobrava-Belgrade virus; HTNV, Hantaan virus; PUUV, Puumala virus; SANGV, Sangassou virus; SEOV, Seoul virus; SNV, Sin Nombre virus; THAIV, Thailand virus; TULV, Tula virus.
Figure 2Quantification of hantavirus RNA in tissue biopsies from a 50-year-old Sochi virus–infected man (patient no. 59), Russia. Two independent approaches were performed to extract RNA from each organ. Quantitative reverse transcription PCR previously developed for DOBV () was used to measure virus load in the analyzed biopsy samples. Three quantitative reverse transcription PCR estimations were conducted for every RNA extraction, followed by calculation of mean values and SDs. Viral RNA levels are shown as genome copies per nanogram of total RNA isolated from the samples. Error bars indicate SD.
Comparisons in clinical outcome, age, and sex of 62 patients with Sochi virus infection, Russia*
| Characteristic | Total | Sex, no. (%) | Age, y, n/N (%) | |||||
|---|---|---|---|---|---|---|---|---|
| No. (%) | Median age, y (range) | M, n = 48 | F, n = 14 | 7–15 | >15 | |||
| No. patients | 62 (100) | 33.3 (7–57) |
|
|
|
|
|
|
| Outcome | ||||||||
| Died | 9 (14.5) | 38.6 (19–53) | 7 (14.6) | 2 (14.3) | 0/6 | 9/56 (16.1) | ||
| Survived | 53 (85.5) | 32.4 (7–57) |
| 41 (85.4) | 12 (85.7) |
| 6/6 (100) | 47/56 (83.9) |
| Illness course | ||||||||
| Severe, including fatal | 37 (59.7) | 33.1 (10–57) |
|
| 3/6 (50) | 34/56 (60.7) | ||
| Moderate, mild | 25 (40.3) | 33.6 (7–57) |
|
| 3/6 (50) | 22/56 (39.3) | ||
*Bold type indicates statistically significant differences between sex or age groups. Comparison of binomial population proportions analysis as implemented in Statlets (NWP Associates, Inc., http://www.mrs.umn.edu/~sungurea/statlets/statlets.htm) indicates rejection of the null hypothesis (claiming that the 2 proportions are equal) at significance level of p<0.05.
Characteristics of 9 deceased patients with Sochi virus infection, Russia*
| Patient no. | Age, y/sex | Hospitalized, no. d after onset | GI symptoms | Max serum creatinine, μmol/L† | Min platelet count, × 109/L‡ | Died, no. d after onset | Clinical and postmortem findings |
|---|---|---|---|---|---|---|---|
| 23 | 33/M | 5 | No | 148 | 70 | 8 | Pneumonia; renal, cardiovascular, multiorgan failure; multiple internal hemorrhages, edema |
| 29 | 29/M | Same day | Yes | 282 | 115 | 6 | Renal, cardiovascular, multiorgan failure; multiple internal hemorrhages, edema |
| 30 | 47/F | 5 | Yes | 391 | 38 | 12 | Renal, lung failure; shock; coagulation disturbance; hemorrhagic gastroenteritis; multiple internal hemorrhages, edema |
| 34 | 53/M | 3 | Yes | 250 | 110 | 10 | Multiorgan failure; coagulation disturbances; multiple internal hemorrhages |
| 42 | 30/M | 14 | Yes | 186 | 67 | 16 | Uremic coma; multiorgan failure; multiple internal hemorrhages |
| 47§ | 41/M | Died before hospitalization | Yes | NR | NR | 3 | Renal failure; multiple internal hemorrhages, edema |
| 48§ | 19/M | 4 | Yes | 192 | 54 | 6 | Renal, cardiovascular failure; RDS, DIC syndrome; bleedings in pituitary, adrenal gland, intestinum, etc. |
| 56 | 35/F | 4 | Yes | 410 | 49 | 6 | Cardiovascular, renal, lung, liver failure; renal tubular necrosis; lung, brain edema |
| 59 | 50/M | 5 | Yes | 310 | 3 | 7 | Renal,cardiovascular failure; RDS; multiple internal hemorrhages; pleurorrhea; lung, brain edema |
*DIC, disseminated intravascular coagulation; GI, gastrointestinal; max, maximum; min, minimum; RDS, respiratory distress syndrome; NR, not reported. †Reference range <96 μmol/L for female patients, <110 μmol/L for male patients. ‡Reference range 150–400 × 109/L §Patient no. 47 was the father in-law of patient no. 48; both lived in the same rural residence.